Philip M. Hanno

The switch to OTC: Are urologic drugs next?Switching a medication from prescription to over-the-counter status comes with challenges and risks, and is not always successful. In this interview, Roger Dmochowski, MD, discusses the pros and cons of OTC medications and explains the hurdles facing potential OTC products for urologic conditions.
Urology, gynecology collaboration addresses rising demandIn this interview, Sarah E. McAchran, MD, discusses the need for urology-gynecology collaboration, the background behind the ABMS recognizing the female pelvic medicine and reconstructive surgery subspecialty, and how barriers to full integration of providers treating pelvic floor disorders can be overcome.
The future of drug delivery in the bladder?
Wellness in urology: Consider non-drug measures up frontIn this interview, Mark A. Moyad, MD, MPH, discusses non-drug interventions for urologic conditions, the difference between prescription drugs and nutraceuticals, and why a heart-healthy diet is a prostate-healthy diet.
AUA 2016: Experts offer guidance on the meetingTo guide you through the 2016 AUA annual meeting and help maximize your time, Urology Times’ editorial board has reviewed the program to identify the key trends and noteworthy research at this year’s meeting.
Physician work force advocate Dr. Cooper rememberedRichard “Buz” Cooper, MD, an outspoken figure on health care work force shortages, dies at 79.
Six tips for preventing burnoutPhysician burnout is a real problem with real consequences. Here are some steps you can take from preventing it from happening to you.
Urologist burnout: Exhaustion jumps, satisfaction slumpsA new study suggests physician burnout is increasing among doctors in many specialties, and the statistics for urology are troubling.
What’s on your colleagues’ wish lists for 2016We asked members of our editorial board what they hope to see in the world of urology in the coming year.
CNS may be path to future voiding dysfunction therapiesIn this interview, Karl-Erik Andersson, MD, PhD, discusses current treatments for common voiding dysfunctions and future directions, including central nervous system agents and combination therapies.